Key facts
- It has raised $7.9M; the latest was Early Stage VC ($7.9M) in Sep 2025.
- Notable investors include SOSV, KB Investment, Hanwha Investment & Securities Company.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Loga
- ·The full record, as it builds
Funding rounds
No funding rounds for Loga are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Loga
Producer of plant-derived bioactive ingredients intended for use in food and cosmetic formulations. The company produces proprietary collagen peptides, undenatured Type 2 collagen, and curcumin extracts free from heavy metals, enabling global beauty and wellness brands to incorporate clean-label, hibiscus-based alternatives into anti-aging, joint health, and skin-nourishing products.
- Sector
- Healthcare
- HQ
- Seongnam, South Korea
- Founded
- 2020
- Employees
- 14
- Website
- plantbyseed.com/
- Ownership
- Privately Held (backing)
Loga doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Loga shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Loga in its N-PORT filings yet. We sweep new filings monthly.